These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16135267)

  • 21. A serological survey of measles, mumps and rubella immunity among school aged children in Western Saudi Arabia.
    Jaber SM
    Saudi Med J; 2006 Jan; 27(1):63-9. PubMed ID: 16432596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outbreak of measles and rubella in refugee transit camps.
    Kouadio IK; Koffi AK; Attoh-Toure H; Kamigaki T; Oshitani H
    Epidemiol Infect; 2009 Nov; 137(11):1593-601. PubMed ID: 19379539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple sclerosis incidence in the era of measles-mumps-rubella mass vaccinations.
    Ahlgren C; Odén A; Torén K; Andersen O
    Acta Neurol Scand; 2009 May; 119(5):313-20. PubMed ID: 19154535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccine-associated measles in a patient treated with natalizumab: a case report.
    Miauton A; Tan R; Pantazou V; Du Pasquier R; Genton B
    BMC Infect Dis; 2020 Oct; 20(1):753. PubMed ID: 33054715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MMR vaccination: new thought.
    Deshmukh V
    Indian Pediatr; 2006 Jun; 43(6):555-6. PubMed ID: 16820670
    [No Abstract]   [Full Text] [Related]  

  • 26. Measles vaccine for adolescents and young adults.
    Med Lett Drugs Ther; 1979 Dec; 21(25):102. PubMed ID: 547158
    [No Abstract]   [Full Text] [Related]  

  • 27. Varicella immunogenicity with 1- and 2-dose regimens of measles-mumps-rubella-varicella vaccine.
    Shinefield HR; Black S; Kuter BJ
    J Infect Dis; 2008 Mar; 197 Suppl 2():S152-5. PubMed ID: 18419390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fear, numbers, and measles.
    Turnbull AE
    Health Commun; 2011 Dec; 26(8):775-6. PubMed ID: 22044390
    [No Abstract]   [Full Text] [Related]  

  • 29. [Vaccination against measles].
    Norrby E
    Tidskr Sver Sjukskot; 1975 Aug; 42(15):4-7. PubMed ID: 1043397
    [No Abstract]   [Full Text] [Related]  

  • 30. [Diagnosis, treatment and prevention of measles].
    Lacroix L; Delaporte E; Siegrist CA; Sudre P; Wyler CA; Gervaix A
    Rev Med Suisse; 2008 Apr; 4(152):920-4. PubMed ID: 18578433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Could the MMR vaccine replace the measles vaccine at one year of age in Egypt?
    Abbassy AA; Barakat SS; Abd El Fattah MM; Said ZN; El Metwally HA
    East Mediterr Health J; 2009; 15(1):85-93. PubMed ID: 19469430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M-M-RII and Varivax.
    Reisinger KS; Brown ML; Xu J; Sullivan BJ; Marshall GS; Nauert B; Matson DO; Silas PE; Schödel F; Gress JO; Kuter BJ;
    Pediatrics; 2006 Feb; 117(2):265-72. PubMed ID: 16452343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measles vaccine gamma globulin in the prevention of cross infection with measles in an acute paediatric ward.
    Glyn-Jones R
    Cent Afr J Med; 1972 Jan; 18(1):4-9. PubMed ID: 4111560
    [No Abstract]   [Full Text] [Related]  

  • 34. A new challenge for Europe: introducing a pediatric quadrivalent vaccine for measles, mumps, rubella, and varicella.
    Ramet J
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S49-55. PubMed ID: 18162247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rubella elimination programme strengthened through measles elimination programme in Catalonia.
    Domínguez A; Torner N; Martínez A; Costa J; Plans P; Ciruela P; Salleras L
    Vaccine; 2006 Feb; 24(9):1433-7. PubMed ID: 16226357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Atypical measles following immunization with inactivated measles virus vaccine (cleavage vaccine)].
    Irtel von Brenndorff A; Enders-Ruckle G; Hagge W
    Med Monatsschr; 1973 Jun; 27(6):265-8. PubMed ID: 4722165
    [No Abstract]   [Full Text] [Related]  

  • 37. What's your measles I.Q.?
    Fiechtner H
    S D Med; 2011 Oct; 64(10):379-80. PubMed ID: 22016927
    [No Abstract]   [Full Text] [Related]  

  • 38. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative studies of measles vaccines prepared from further attenuated strains Schwarz and SEVAC].
    Adam E; Fosenbauerová E; Domorázková E; Kratochvílová M; Kubátová E; Mares I; Drevo M; Svandová E
    Cesk Pediatr; 1968 Jul; 23(7):581-93. PubMed ID: 5681931
    [No Abstract]   [Full Text] [Related]  

  • 40. The eradication of measles.
    S Afr Med J; 1967 Aug; 41(31):766-7. PubMed ID: 6051093
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.